Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy...
Investigational
Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma -- a...
As SARS-CoV-2 continues to spread and mutate, it's important to identify new treatment options. Molnupiravir is an investigational oral antiviral...
Houston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third...
Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high...